<?xml version='1.0' encoding='utf-8'?>
<document id="32213237"><sentence text="Effects of atorvastatin on talinolol absorption: A potential drug-drug interaction."><entity charOffset="11-23" id="DDI-PubMed.32213237.s1.e0" text="atorvastatin" /><entity charOffset="27-36" id="DDI-PubMed.32213237.s1.e1" text="talinolol" /><pair ddi="false" e1="DDI-PubMed.32213237.s1.e0" e2="DDI-PubMed.32213237.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s1.e0" e2="DDI-PubMed.32213237.s1.e1" /></sentence><sentence text="In this study, we aimed to determine the drug-drug interaction potential between atorvastatin (ATOR), and talinolol (TAL)"><entity charOffset="81-93" id="DDI-PubMed.32213237.s2.e0" text="atorvastatin" /><entity charOffset="95-99" id="DDI-PubMed.32213237.s2.e1" text="ATOR" /><entity charOffset="106-115" id="DDI-PubMed.32213237.s2.e2" text="talinolol" /><entity charOffset="117-120" id="DDI-PubMed.32213237.s2.e3" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e0" e2="DDI-PubMed.32213237.s2.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e0" e2="DDI-PubMed.32213237.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e0" e2="DDI-PubMed.32213237.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e0" e2="DDI-PubMed.32213237.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e1" e2="DDI-PubMed.32213237.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e1" e2="DDI-PubMed.32213237.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e1" e2="DDI-PubMed.32213237.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e2" e2="DDI-PubMed.32213237.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32213237.s2.e2" e2="DDI-PubMed.32213237.s2.e3" /></sentence><sentence text=" Concentration-dependent effects of ATOR on the intestinal permeability of TAL were investigated by an in situ intestinal perfusion method"><entity charOffset="36-38" id="DDI-PubMed.32213237.s3.e0" text="ATOR" /><entity charOffset="75-77" id="DDI-PubMed.32213237.s3.e1" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s3.e0" e2="DDI-PubMed.32213237.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s3.e0" e2="DDI-PubMed.32213237.s3.e1" /></sentence><sentence text=" Dose-dependent effects of ATOR on TAL exposure were evaluated by measuring plasma concentrations after oral administration in rats"><entity charOffset="27-29" id="DDI-PubMed.32213237.s4.e0" text="ATOR" /><entity charOffset="35-37" id="DDI-PubMed.32213237.s4.e1" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s4.e0" e2="DDI-PubMed.32213237.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s4.e0" e2="DDI-PubMed.32213237.s4.e1" /></sentence><sentence text=" ATOR slightly changed the intestinal secretion of TAL in jejunum but not in colon"><entity charOffset="1-3" id="DDI-PubMed.32213237.s5.e0" text="ATOR" /><entity charOffset="51-53" id="DDI-PubMed.32213237.s5.e1" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s5.e0" e2="DDI-PubMed.32213237.s5.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s5.e0" e2="DDI-PubMed.32213237.s5.e1" /></sentence><sentence text=" Plasma AUC levels of TAL were elevated by co-administration of ATOR at low and high doses whereas medium doses of ATOR resulted in a decrease in TAL bioavailability"><entity charOffset="64-66" id="DDI-PubMed.32213237.s6.e0" text="ATOR" /><entity charOffset="115-117" id="DDI-PubMed.32213237.s6.e1" text="ATOR" /><entity charOffset="22-24" id="DDI-PubMed.32213237.s6.e2" text="TAL" /><entity charOffset="146-148" id="DDI-PubMed.32213237.s6.e3" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e2" e2="DDI-PubMed.32213237.s6.e2" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e2" e2="DDI-PubMed.32213237.s6.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e2" e2="DDI-PubMed.32213237.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e2" e2="DDI-PubMed.32213237.s6.e3" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e0" e2="DDI-PubMed.32213237.s6.e0" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e0" e2="DDI-PubMed.32213237.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e0" e2="DDI-PubMed.32213237.s6.e3" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e1" e2="DDI-PubMed.32213237.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s6.e1" e2="DDI-PubMed.32213237.s6.e3" /></sentence><sentence text=" However, these changes were not statistically significant" /><sentence text=" In our study, the pharmacokinetics of TAL were not affected by the concurrent use of ATOR in rats"><entity charOffset="86-88" id="DDI-PubMed.32213237.s8.e0" text="ATOR" /><entity charOffset="39-41" id="DDI-PubMed.32213237.s8.e1" text="TAL" /><pair ddi="false" e1="DDI-PubMed.32213237.s8.e1" e2="DDI-PubMed.32213237.s8.e1" /><pair ddi="false" e1="DDI-PubMed.32213237.s8.e1" e2="DDI-PubMed.32213237.s8.e0" /></sentence><sentence text=" In conclusion, it should be considered that complex interplay between the efflux and uptake transporters in the tissues and inhibition of these transporters by modulating agents may overshadow individual effects of each other" /><sentence text="" /></document>